A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer

NCT07110571 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer
Gastroesophageal-junction Cancer

Interventions

DRUG: Adebrelimab Injection
DRUG: SHR-A1811 for Injection
DRUG: SHR-A1904 for Injection
DRUG: SHR-8068 Injection

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.